﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Nephropathology</JournalTitle>
      <Issn>2251-8363</Issn>
      <Volume>7</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2018</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Phospholipase A2 receptor (PLA2R) related membranous nephropathy - not specific for idiopathic cases any more</ArticleTitle>
    <FirstPage>11</FirstPage>
    <LastPage>14</LastPage>
    <ELocationID EIdType="doi">10.15171/jnp.2018.04</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Bahar</FirstName>
        <LastName>Bastani</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/jnp.2018.04</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>09</Month>
        <Day>13</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>11</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <Abstract>Context: Membranous nephropathy is among the most common causes of nephrotic syndrome in adults. Evidence Acquisitions: PubMed, EBSCO, Web of Science, directory of open access journals (DOAJ), EMBASE, and Google Scholar with keywords of phospholipase A2 receptor, PLA2R, membranous nephropathy, nephrotic syndrome, idiopathic nephrotic syndrome and glomerulonephritis have been searched. Results: The recent finding that around 70%-80% of the idiopathic cases of membranous nephropathy express Phospholipase A2 receptor (PLA2R) in their kidney biopsies and antiPLA2R antibody in their serum was initially considered specific to the idiopathic cases. However, more recent studies have shown that while PLA2R glycoprotein expression, and anti-PLA2R antibodies, are specific to membranous nephropathy and are not seen in other glomerulonephritides, they can be as frequently expressed in certain secondary forms of membranous nephropathy. Conclusions: In this communication we intend to briefly review the new data regarding tissue and sero-positivity for PLA2R in different types of secondary membranous nephropathy, as well as pathologic and immunofluorescence features of them as compared to the idiopathic cases.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Phospholipase A2 receptor</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">PLA2R</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Membranous nephropathy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Nephrotic syndrome</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Idiopathic nephrotic syndrome</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Glomerulonephritis</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>